Member of NICE myeloma clinical guidelines group. Guidelines currently under development.
Member of NCRI haematological oncology myeloma clinical trials subgroup.
Dr Jenner has conducted clinical research into the optimal treatment strategies for myeloma and in to the prognostic significance of cytogenetic abnormalities in myeloma. He has also participated in the development of BCSH and NICE myeloma guidelines.
Co-authored 2013 update to British Committee of Standards in Haematology guidelines for the diagnosis and management of multiple myeloma.